Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-23
1994-02-08
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544 90, 544229, 544284, 544287, A61K 31505, C07D23991, C07D40310, C07D40114
Patent
active
052848523
ABSTRACT:
This disclosure describes novel 2,3,6-substituted quinazolinones having the formula: ##STR1## wherein R.sup.6, X and R are as described in the specification which have activity as angiotensin II (AII) antagonists.
REFERENCES:
patent: 5202322 (1993-04-01), Allen
patent: 5204354 (1993-04-01), Chakravarty et al.
patent: 5238942 (1993-08-01), Chakravarty et al.
patent: 5240928 (1993-08-01), Allen et al.
patent: 5252574 (1993-10-01), Allen et al.
Levin Jeremy I.
Venkatesan Aranapakam M.
American Cyanamid Company
Bernhardt Emily
Szatkowski T. S.
LandOfFree
Angiotensin II receptor blocking 2,3,6-substituted quinazolinone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor blocking 2,3,6-substituted quinazolinone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor blocking 2,3,6-substituted quinazolinone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-698103